RxDoctor Payments Data

Kelly Ortwine, MD

Family Medicine · Rochester Hills, MINPI 1598747941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AbbVie at 51.4% of the total. That places this record below the midpoint for family medicine clinicians in MI, where the typical reported total is $260.

$332in general payments, 2019–2025

Across 19 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$170
  • Pfizer$68
  • GSK$62
  • Amarin Pharma, Inc.$19
  • Sunovion Pharmaceuticals Inc.$12

What the payments were for

  • Food & beverage$332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)9$170
Pfizer5$68
GSK3$62
Amarin Pharma, Inc.1$19
Sunovion Pharmaceuticals Inc.1$12

How this compares

$332 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$118,050
Medicare patients
333
Services billed
3,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide81$89,564
OzempicSemaglutide51$61,276
EliquisApixaban44$44,248
JardianceEmpagliflozin28$42,697
JanuviaSitagliptin Phosphate20$30,654
XareltoRivaroxaban19$24,047
FarxigaDapagliflozin Propanediol19$22,640
TrulicityDulaglutide17$20,839
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,931
AbrysvoRsv Vacc, Pref A And Pref B/Pf35$11,155
Atorvastatin Calcium830$9,503
ShingrixVaricella-Zoster Ge/As01b/Pf38$8,431
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$8,218
Levothyroxine Sodium507$6,017
Losartan Potassium353$5,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$68$55,40379 claims
GSKTrelegy Ellipta, Shingrix$62$28,36252 claims
AbbVieSynthroid$170$2,16238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →